Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Nove možnosti citopatološke diagnostike raka sečnega mehurja s testom UroVysion
Avtorji:ID Strojan Fležar, Margareta (Avtor)
ID Srebotnik-Kirbiš, Irena (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (501,17 KB)
MD5: 405065A75CAC0B105E564BC9D4BDC78E
PID: 20.500.12556/dirros/332157d7-d06e-461c-92c1-6a74f542b07e
 
Jezik:Slovenski jezik
Tipologija:1.04 - Strokovni članek
Organizacija:Logo OI - Onkološki inštitut Ljubljana
Ključne besede:sečni mehur, rak (medicina), citološka diagnostika
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2009
Št. strani:str. 130-132, 153
Številčenje:Letn. 13, št. 2
PID:20.500.12556/DiRROS-8619 Novo okno
UDK:616.62-006-07
ISSN pri članku:1408-1741
URN:URN:NBN:SI:doc-9XB4AZO1
COBISS.SI-ID:27082969 Novo okno
Avtorske pravice:by Authors
Opomba:BSDOCID151741;
Datum objave v DiRROS:31.08.2018
Število ogledov:2600
Število prenosov:728
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Onkologija. strokovni časopis za zdravnike
Skrajšan naslov:Onkologija
Založnik:Onkološki inštitut
ISSN:1408-1741
COBISS.SI-ID:65324032 Novo okno

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:31.08.2018

Sekundarni jezik

Jezik:Angleški jezik
Naslov:New Promises of Cytopathologic Diagnostics of Bladder cancer by Using UroVysion™
Povzetek:Cytopathologic examination of the urine and bladder washing is a standard method for the detection of primary bladder cancer in symptomatic patients or in patients with hematuria. The method is also very useful to follow the patients after treatment in order to detect recurrence of bladder cancer which occurs in a significant percentage of patients. Cytopathologic examination is highly accurate for the diagnosis of high grade urothelial carcinoma and carcinoma in situ. However, the method is recognized as being unreliable for the detection of low grade urothelial neoplasms. Obvious cellular and nuclear morphological signs of malignancy can be reliably recognized in high grade papillary, invasive and in situ urothelial carcinoma. Thus, less pronounced cellular atypia pose everyday diagnostic problems and atypia of low grade papillary neoplasms cannot be always reliably differentiated from atypia of some benign and post-treatment reactive changes. In the last decade a number of new urinary markers have been developed to overcome low sensitivity of urinary cytology. Although most of these tests are highly sensitive, they have lower specificity than cytology. The UroVysion test seems the most promising among the new tests. By the method of multitarget fluorescent in situ hybridisation (FISH), the test can detect several cytogenetic changes characteristic for different grades of bladder cancer. Therefore, the UroVysion test is useful for assessing neoplastic nature of cytologically undetermined atypical cells. The most recent reports claim that the UroVysion test can even detect bladder cancer before morphological changes are diagnosed in urine cytology.


Arhiv

niGradiv

Nazaj